Top Markets
#1 B3 (Base) B3 (Base) +14.17%
#2 Fake World Assets Fake World Assets +11.22%
#3 Janction Janction +9.46%
#4 Verus Coin Verus Coin +7.95%
#5 TENDIES TENDIES +6.38%
#6 Status Status +4.85%
#7 GoPlus Security GoPlus Security +4.76%
#8 龙虾 (Lobster) 龙虾 (Lobster) +4.30%
#9 Provenance Blockchain Provenance Blockchain +3.88%
#10 Everything Everything +3.72%
Coin of the day
B3 (Base) B3 (Base)
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Ultimovacs ASA Ultimovacs ASA

Ultimovacs ASA

ULTI
Rangering i aksjer #34179
Ultimovacs ASA is a pharmaceutical company based in Oslo, Norway, established... Ultimovacs ASA is a pharmaceutical company based in Oslo, Norway, established in 2011. The firm specializes in developing immunotherapies to combat various cancers. Its main product in development is UV1, a peptide vaccine engineered to stimulate a T-cell immune response against telomerase, an antigen found widely across different cancer types.
Aksjekurs
$0.17687105
Sist synkronisert: 2025-04-01
Markedsverdi
$6.08M
Endring (1 dag)
-89.96%
Endring (1 år)
0.00%
Land
NO
Handel Ultimovacs ASA (ULTI)

Kategori

Healthcare
EPS for Ultimovacs ASA (ULTI)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Ultimovacs ASA er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Ultimovacs ASA fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE